Quipt Home Medical (TSE:QIPT – Free Report) had its target price reduced by Stifel Nicolaus from C$8.40 to C$7.50 in a report published on Thursday,BayStreet.CA reports. Stifel Nicolaus currently has a buy rating on the stock.
Quipt Home Medical Stock Performance
TSE QIPT opened at C$3.56 on Thursday. Quipt Home Medical has a 1 year low of C$3.28 and a 1 year high of C$6.98. The stock’s 50-day moving average price is C$3.72 and its two-hundred day moving average price is C$4.11. The company has a market cap of C$153.40 million, a PE ratio of -20.94 and a beta of 1.01.
Quipt Home Medical Company Profile
Featured Stories
- Five stocks we like better than Quipt Home Medical
- 10 Best Airline Stocks to Buy
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- 3 Healthcare Dividend Stocks to Buy
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- How to Start Investing in Real Estate
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.